Teva CAO Reports RSU Grant and Vesting of Shares
TEVA PHARMACEUTICAL INDUSTRIES LTD
Subscribe to track TEVA
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Teva CAO Reports RSU Grant and Vesting of Shares
Company: TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) Form: 4 | Filed: 2026/03/06 Significance: Low
Insider: Weiss Amir Title: Chief Accounting Officer | Relationship: Officer
Transaction: • Type: Grant (Restricted Share Units) • Shares: 11,280 • Price: $0.00 • Value: $0 (Compensation) • Owned After: 11,280 (Derivative)
Key Insight: Routine executive compensation filing reporting the grant of new RSUs and the vesting of previously granted units. No open market trading activity.
Market Context: Transaction is negligible relative to Teva's $122.87B market cap and 1.15B shares outstanding.
Comprehensive Analysis
SEC Filing Analysis: TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)
Executive Summary
- Trading Significance: Low
- Key Takeaway: Chief Accounting Officer reports routine annual RSU grant and vesting of prior awards.
- Market Impact: Neutral - This is standard compensation activity with no signal of insider sentiment regarding stock value.
Company Information
| Field | Value |
|---|---|
| Company | TEVA PHARMACEUTICAL INDUSTRIES LTD |
| Ticker Symbol | TEVA |
| CIK | 0000818686 |
| Industry | Pharmaceutical Preparations |
Insider Information
| Field | Value |
|---|---|
| Name | Weiss Amir |
| CIK | 0001897057 |
| Title/Position | Chief Accounting Officer |
| Relationship | Officer |
Transaction Details
| Field | Value |
|---|---|
| Form Type | 4 |
| Transaction Date | 2026-03-04 |
| Transaction Code | A (Grant) & M (Exercise/Vesting) |
| Security Type | Restricted Share Units / Ordinary Shares |
| Shares Granted | 11,280 |
| Shares Vested | 16,329 |
| Price Per Share | $0.00 |
| Total Value | $0 (Compensation) |
| Ownership Type | Direct |
Financial Impact Assessment
Transaction Materiality
| Metric | Value |
|---|---|
| Transaction Value | $0 (Non-cash grant) |
| % of Market Cap | 0.00% |
| Shares Transacted | 11,280 (Grant) |
| % of Shares Outstanding | ~0.001% |
| Materiality Assessment | Low |
Impact Evaluation
- Market Cap Context: With a market capitalization of $122.87 billion, this compensation grant is financially immaterial to the broader market.
- Dilution Impact: The grant of 11,280 RSUs represents approximately 0.001% of the 1.15 billion shares outstanding, resulting in zero meaningful dilution for shareholders.
- Transaction Significance: The filing represents standard corporate governance (annual equity awards) rather than an investment decision by the insider.
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: Routine compensation filings do not typically influence stock price direction as they do not reflect open market supply/demand or insider sentiment.
Volume & Sentiment
- Expected Volume Impact: None.
- Sentiment Indicator: Neutral.
Additional Context
Transaction Notes
- Details: The insider received a grant of 11,280 RSUs vesting over 4 years (2027-2030). Simultaneously, 16,329 previously granted RSUs vested into Ordinary Shares.
- Holdings: Following these transactions, the insider holds 27,158 Ordinary Shares directly.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.